Medicare Enrolled

Dr. Chris Threatt, MD

Urology Physician · Redwood City, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Mixed engagement
801 BREWSTER AVE STE 240, Redwood City, CA 94063
6504656038
In practice since 2005 (20 years)
NPI: 1568466589 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Threatt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Threatt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Threatt

Dr. Chris Threatt is an urology physician in Redwood City, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Threatt performed 2,554 Medicare services across 1,336 unique beneficiaries.

Between the years covered by Open Payments, Dr. Threatt received a total of $21,944 from 49 pharmaceutical and/or device companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Threatt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 31% volume in CA $21,944 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,554
Medicare services
Top 31% in CA for urology physician
1,336
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~128 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
913 $111 $416
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
364 $10 $98
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
236 $11 $217
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
236 $13 $109
Lower leg neurostimulator electrode insertion
A procedure to place an electrode in the lower leg for neurostimulation therapy.
199 $117 $505
Injection, garamycin, gentamicin, up to 80 mg 184 $2 $6
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
101 $235 $619
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
62 $143 $586
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
60 $79 $324
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
58 $22 $84
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
40 $167 $552
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
31 $64 $282
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
27 $3 $12
Urethral dilation using endoscope
A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage.
17 $326 $1,117
New patient office visit, complex (60-74 min) 14 $203 $731
Laser vaporization of prostate
A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment.
12 $582 $6,380
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$21,944
Total received (2018-2024)
Avg $3,135/year across 7 years
Top 11% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
174
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$13,176 (60.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,011 (22.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,701 (16.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$55 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$13,673
2023
$486
2022
$3,283
2021
$1,043
2020
$2,479
2019
$571
2018
$408

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Olympus America Inc.
$13,176
Sumitomo Pharma America, Inc.
$347
Endo USA, Inc.
$100
COLOPLAST CORP
$36
Axonics, Inc.
$14
Top 3 companies account for 99.6% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus America Inc.
$13,190
Valencia Technologies Corporation
$2,575
Arthrex, Inc.
$2,104
Sumitomo Pharma America, Inc.
$640
Teleflex LLC
$436
UROVANT SCIENCES INC
$402
Endo Pharmaceuticals Inc.
$342
Boston Scientific Corporation
$274
kaleo, Inc.
$133
Astellas Pharma US Inc
$122
NeoTract Inc.
$115
Allergan Inc.
$102
Endo USA, Inc.
$100
Roche Diagnostics Corporation
$85
Allergan, Inc.
$84
AbbVie, Inc.
$84
PFIZER INC.
$81
Bausch Health US, LLC
$75
Coloplast Corp
$73
Hologic, LLC
$70
Janssen Biotech, Inc.
$66
Evofem Biosciences, Inc.
$58
MAYNE PHARMA INC.
$54
COLOPLAST CORP
$52
AbbVie Inc.
$47
Biohaven Pharmaceutical Holding Company Ltd.
$39
TherapeuticsMD, Inc.
$37
Hologic Sales and Service, LLC
$37
Ferring Pharmaceuticals Inc.
$36
AMAG Pharmaceuticals, Inc.
$35
Photocure Inc
$32
Axonics, Inc.
$29
Cranial Technologies, Inc
$28
PROCEPT BioRobotics Corporation
$26
BOSTON SCIENTIFIC CORPORATION
$25
Becton, Dickinson and Company
$23
Bayer HealthCare Pharmaceuticals Inc.
$23
Dendreon Pharmaceuticals LLC
$23
Rochester Medical Corporation
$20
Avion Pharmaceuticals
$20
C. R. BARD, INC. & SUBSIDIARIES
$19
UROGEN PHARMA, INC.
$19
Exeltis, USA Inc.
$18
ABBVIE INC.
$18
Aspira Women's Health Inc
$17
Agiliti Surgical, Inc.
$16
Sage Therapeutics, Inc.
$15
Merck Sharp & Dohme LLC
$14
Antares Pharma, Inc.
$11
Top 3 companies account for 81.4% of all-time payments
Associated products mentioned in payments ›
ACESSA PROVU SYSTEM · AMS · ANNOVERA · APLENZIN · APTIMA · AQUABEAM ROBOTIC SYSTEM · AUVI-Q · AVEED · Altis · Androgel · Aptima HPV · Axonics · Axonics r-SNM System · BD Onclarity · BOTOX · BOTOX THERAPEUTIC · CINtec PLUS Cytology · Cysview · Divigel · Doc Band · ERLEADA · Erleada · GARDASIL 9 · GEMTESA · GENERAL BPH · GREENLIGHT · IMVEXXY · INTRAROSA · JELMYTO · LITHOVUE EMPOWER · LO LOESTRIN FE · Lupron · Lupron Depot · MYFEMBREE · MYRBETRIQ · NOCDURNA · NURTEC ODT · Nubeqa · OVA1 · Otrexup · PENILE & TESTICULAR RECONSTRUCTN · PREVNAR 13 · PROVENGE · Phexxi · QULIPTA · RS Harmony Test Related Products · SLYND · SOLTIVE · SOLYX · SPEEDICATH · TD BenchMark Platforms · THINPREP 2000 PROCESSOR · TOVIAZ · UBRELVY · UROLIFT SYSTEM · UroLift · UroLift System · VESICARE · Veozah · XIAFLEX · XTANDI · ZULRESSO · eCoin Device Kit · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type.

Looking for an urology physician in Redwood City?
Compare urology physicians in the Redwood City area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
184
Per 100K population
24.7
County median income
$156,000
Nearest hospital
KAISER FOUNDATION HOSPITAL - REDWOOD CITY
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Threatt is a clinical cardiology specialist, with moderate Medicare volume, with mixed engagement industry engagement in the top 11% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Threatt experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Threatt performed 913 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Threatt receive payments from pharmaceutical companies?
Yes. Dr. Threatt received a total of $21,944 from 49 companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Threatt's costs compare to other urology physicians in Redwood City?
Dr. Threatt's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Threatt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →